Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

62.46 -5.95 (-8.70%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Establishment Labs (ESTA) Q3 2026 Earnings Call Transcript ↗
Revenue surged 33.9% as company hit first positive free cash flow quarter. 
Via The Motley Fool
Topics Earnings
News headline image
What Establishment Labs (ESTA) Said on Its Q3 Earnings Call ↗
Establishment Labs (NASDAQ:ESTA) reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the... 
Via MarketBeat
Topics Earnings
News headline image
Establishment Labs® Reports Third Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Holdings (NASDAQ:ESTA) Meets Minervini Trend Template and High Growth Momentum Criteria ↗
Via Chartmill
Establishment Labs Holdings (NASDAQ:ESTA) Beats Revenue Estimates and Raises Full-Year Guidance in Q1 2026 Earnings ↗
Via Chartmill
News headline image
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
News Provided by USA News Group on behalf of Conexeu Sciences Inc. 
From USA News Group
Via GlobeNewswire
News headline image
Establishment Labs Q2 Earnings Call Highlights ↗
Establishment Labs (NASDAQ:ESTA) reported second-quarter revenue growth of 31.7% year over year, driven by continued rapid expansion in the United States, rising adoption of its Minimally Invasive... 
Via MarketBeat
Topics Earnings
News headline image
Establishment Labs® Reports Second Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock ↗
Jim Cramer recommends buying Howmet Aerospace Inc. (NYSE: HWM) and Farmers National Banc Corp. (NASDAQ: FMNB), and says Bending Spoons S.p.A. (NASDAQ: BSP) is a good software company. He is not a fan... 
Via Benzinga
News headline image
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction. ↗
This global medical device innovator, known for advanced breast implant systems, reported a notable insider sale in recent filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
From Biotech Insider
Via GlobeNewswire
News headline image
Establishment Labs® Appoints Taylor Harris to Board of Directors
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
From Biotech Insider
Via GlobeNewswire
News headline image
Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗
Establishment Labs develops advanced silicone implants and medical devices for global plastic surgery markets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc. 
From Biotech Insider
Via GlobeNewswire
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
From Energy Metal News
Via GlobeNewswire
News headline image
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
From Route 92 Medical, Inc.
Via GlobeNewswire
News headline image
Core Natural Resources Stock Trails the Market, but One Fund Is Buying Up Shares ↗
This U.S.-based coal producer operates integrated mining and export facilities, supplying power generators and industrial clients worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund’s $23 Million Appian Buy Amid AI Automation Growth and a 40% Stock Drop ↗
Appian provides low-code automation tools for enterprise clients, enabling rapid digital transformation across multiple industries. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Warrior Met Coal Stock Has Soared 80%. One Investor Just Trimmed $32 Million ↗
Warrior Met Coal supplies metallurgical coal to global steelmakers, operating two underground mines in Alabama for export markets. 
Via The Motley Fool
Topics Energy Regulatory Compliance Supply Chain
News headline image
ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story ↗
This global medtech firm specializing in advanced implant solutions reported a notable insider sale amid a year of strong share performance. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth ↗
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S. market. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ESTA Q1 2026 Earnings Transcript ↗
ESTA Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Establishment Labs Reports First Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Refinances Credit Facility
From Establishment Labs Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.